TY - JOUR
T1 - TLR2 agonistic small molecules
T2 - Detailed structure-activity relationship, applications, and future prospects
AU - Kaur, Arshpreet
AU - Kaushik, Deepender
AU - Piplani, Sakshi
AU - Mehta, Surinder K.
AU - Petrovsky, Nikolai
AU - Salunke, Deepak B.
PY - 2021/1/14
Y1 - 2021/1/14
N2 - Toll-like receptors (TLRs) are the pattern recognition receptors (PRRs) that recognize pathogen-associated molecular patterns (PAMPs) in microbial species. Among the various TLRs, TLR2 has a special place due to its ability to sense the widest repertoire of PAMPs owing to its heterodimerization with either TLR1 or TLR6, broadening its ligand diversity against pathogens. Various scaffolds are reported to activate TLR2, which include naturally occurring lipoproteins, synthetic lipopeptides, and small heterocyclic molecules. We described a detailed SAR in TLR2 agonistic scaffolds and also covered the design and chemistry for the conjugation of TLR2 agonists to antigens, carbohydrates, polymers, and fluorophores. The approaches involved in delivery of TLR2 agonists such as lipidation of antigen, conjugation to polymers, phosphonic acids, and other linkers to achieve surface adsorption, liposomal formulation, and encapsulating nanoparticles are elaborated. The crystal structure analysis and computational modeling are also included with the structural features that facilitate TLR2 activation.
AB - Toll-like receptors (TLRs) are the pattern recognition receptors (PRRs) that recognize pathogen-associated molecular patterns (PAMPs) in microbial species. Among the various TLRs, TLR2 has a special place due to its ability to sense the widest repertoire of PAMPs owing to its heterodimerization with either TLR1 or TLR6, broadening its ligand diversity against pathogens. Various scaffolds are reported to activate TLR2, which include naturally occurring lipoproteins, synthetic lipopeptides, and small heterocyclic molecules. We described a detailed SAR in TLR2 agonistic scaffolds and also covered the design and chemistry for the conjugation of TLR2 agonists to antigens, carbohydrates, polymers, and fluorophores. The approaches involved in delivery of TLR2 agonists such as lipidation of antigen, conjugation to polymers, phosphonic acids, and other linkers to achieve surface adsorption, liposomal formulation, and encapsulating nanoparticles are elaborated. The crystal structure analysis and computational modeling are also included with the structural features that facilitate TLR2 activation.
KW - Polyacrylamide
KW - Lipids
KW - Peptides and proteins
KW - Agonists
KW - Monomers
UR - http://www.scopus.com/inward/record.url?scp=85099171080&partnerID=8YFLogxK
U2 - 10.1021/acs.jmedchem.0c01627
DO - 10.1021/acs.jmedchem.0c01627
M3 - Review article
C2 - 33346636
AN - SCOPUS:85099171080
SN - 0022-2623
VL - 64
SP - 233
EP - 278
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 1
ER -